Insider transactions

David Rickey

CIK 1184566 · last filed 2017-11-29

David Rickey is a corporate insider who has filed 55 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for CYTX, was dated Nov 29, 2017. Across all open-market trades the lifetime net is +$642.9K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
55
Lifetime Open-Market Net
$642.9K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

CYTX price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PLUS THERAPEUTICS, INC. (CYTX) Delisted Director 56,281 — — $642.9K 53 2017-11-29
NETLIST INC (NLST) Delisted Director — — — $0 2 2008-11-24

Recent Filings

55 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-11-29 PLUS THERAPEUTICS, INC. (CYTX) Delisted Exer (X) — $0 EDGAR
2017-01-27 PLUS THERAPEUTICS, INC. (CYTX) Delisted Grant (A) — $0 EDGAR
2016-06-15 PLUS THERAPEUTICS, INC. (CYTX) Delisted Buy (P) +5,000 $10.5K EDGAR
2016-06-15 PLUS THERAPEUTICS, INC. (CYTX) Delisted Exer (X) +22,000 $0 EDGAR
2016-03-09 PLUS THERAPEUTICS, INC. (CYTX) Delisted Buy (P) +150,000 $28.3K EDGAR
2016-01-04 PLUS THERAPEUTICS, INC. (CYTX) Delisted Grant (A) — $0 EDGAR
2015-08-31 PLUS THERAPEUTICS, INC. (CYTX) Delisted Buy (P) +56,000 $17.6K EDGAR
2015-08-28 PLUS THERAPEUTICS, INC. (CYTX) Delisted Buy (P) +75,000 $23.1K EDGAR
2015-08-24 PLUS THERAPEUTICS, INC. (CYTX) Delisted Buy (P) +50,000 $18.8K EDGAR
2015-08-20 PLUS THERAPEUTICS, INC. (CYTX) Delisted Buy (P) +48,600 $19.1K EDGAR
Showing 1–10 of 55
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.